Events

Featured Events

• 
  
  Private Investor Network interview with CEO Dr. Tony Sedgwick, April 2012
  
  18th April 2012

  Silence Therapeutics’ CEO Dr. Tony Sedgwick spoke at the Private Investor Network (Twitter: @PIN_Conferences) on April 18th about Silence’s role in the field of RNAi.

  Audio Recording

   
• 
  
  Silence therapeutics’ CEO: Dr Tony Sedgwick presents the unaudited preliminary results for the year ended 31 December 2011
  
  31st December 2011
  Audio Recording

Upcoming Events

• 
  Oligonucleotide Therapeutics Discovery ( part of Tides)
  22nd - 23rd May 2012
  Las Vegas
  
• 
  3rd RNAi Research and Therapeutics Conference
  30th - 31st May 2012
  Boston
  
• 
  RNAi, miRNA, siRNA & Nanotechnology Conference
  11th - 12th June 2012
  London
  

  
  

  Slideshow

  Silence Investor Presentation Unaudited Preliminary Results 2012